Regorafenib Induces the Apoptosis of Gastrointestinal Cancer-Associated Fibroblasts by Inhibiting AKT Phosphorylation

Investigators established two in vivo tumor models, the cancer cell line HCT116 with or without MSCs and treated them with regorafenib.